EUCTR2012-002988-10-ES进行中（未招募）1 期
Randomized, double-blind, placebo-controlled trial to compare the effect, three months of follow-on pulse pressure and vascular function of isosorbide mononitrate extended release, associated with antihypertensive treatment in patients over 65 years refractory isolated systolic hypertension - isosorbide mononitrate extended release, associated with antihypertensive treatment in patients over
Fundación para la investigacion Biomedica0 个研究点开始时间: 2012年9月26日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •?Patients aged 65 or over of both genders, belong to some primary care or Hypertension?s Unit of Hospital La Princesa, who will be given their written informed consent to participate in the study.
- •?Patients with refractory ISH defined as SBP ?140 mmHg and DBP <90 mmHg, despite treatment with three drugs as maximum doses, one of them diuretic, during at least one month before the start
- •?Good adherence to treatment, defined as a good response to all questions of Morisky-Green?s test.
- •?SBP between 140 y 179 mmHg
- •?Ability to understand study procedures and to comply with them for the entire length of the study.
- •?Life expectancy greater than 1 year
- •?Signing the informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 154
排除标准
- •?Current treatment with nitrites or intolerance to them
- •?Atrial fibrillation
- •?Secondary hypertension
- •?Patients with physical, mental or important communications limitations.
- •?life expectancy less than one year
- •?Malignancy
- •?Congestive heart failure III-IV NYHA
- •?Renal failure IV-V (glomerular filtration measured with MDRD ?30 ml/min)
- •?Hepatic failure
- •?Concomitant treatment with phosphodiesterase 5 during previous month at the beginning of study
- •?Severe anaemia (haemoglobin ?8g/dl)
- •?Simultaneous participation in another clinical trial.
- •?Inability or unwillingness of individual or legal guardian/representative to give written informed consent.
- •?Subjects who don?t give their written consent to participate in the study.
- •?Any other circumstance that, as the researcher criteria, advises against the inclusion to the study
研究者
相似试验
进行中（未招募）
1 期
Randomized, double-blind, placebo-controlled trial to determine the capacity of VAK694 to elicit long term immune tolerance when combined with subcutaneous allergen immunotherapy for the treatment of seasonal allergic rhinitisEUCTR2009-013429-40-GBovartis Pharma Services AG
招募中
不适用
The effect of iodine supplementation on cognition in school-aged childreIodine deficiencyDiet and Nutrition - Other diet and nutrition disordersACTRN12609001026213niversity of Adelaide350
进行中（未招募）
1 期
Study of RV521 for the treatment of adults who have received a blood cell transplant and that have a respiratory infection caused by the virus RSVEUCTR2019-003746-33-FRReViral Ltd.200
招募中
3 期
Efficacy of Aripiprazole adjunctive treatment on body weight, metabolic parameters, clinical efficacy, and adverse events in people with psychotic disorders on treatment with Clozapine â?? A randomized, double-blind, placebo-controlled trialSchizoaffective disorderAntipsychotic induced weight gainMetabolic syndromeCTRI/2013/02/003397Christian Medical College60
进行中（未招募）
1 期
Efficacy and safety of intravenous neridronic acid in CRPSEUCTR2016-003833-91-ESGrünenthal GmbH360